Video Intervention to Improve Understanding of Diabetic Retinopathy at Zuckerberg San Francisco General Hospital and Trauma Center

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of California, San Francisco

About this trial

The study will evaluate whether videos can improve understanding of diabetic eye disease, and follow-up rates in the eye clinic.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Diagnosis of diabetes mellitus with or without diabetic retinopathy

Scheduled visit to ZSFG clinic is specifically for diabetes mellitus or diabetic retinopathy care

Able to speak and understand English or Spanish

Disqualifiers

Unable to view or understand the videos due to significant vision obstruction or impairment

Trial design

Design model

Parallel

Treatments tested in this trial

  • Animated Videos

    Behavioral

    Animated videos (in English and Spanish) that describe diabetic retinopathy.

Treatment groups

150 Participants
are divided into 2 treatment groups
Group A: Experimental GroupExperimental treatment 1 intervention
Group B: ControlNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Change in Knowledge Concordance Assessed through Validated Questionarres

Validated questionnaires in Qualtrics consisting of multiple choice questions and scales from 0 through 10 will be used to assess knowledge concordance before and after the patient's appointment. The change in concordance will be determined for each patient.

Time frame
12 months

Secondary outcomes

1

Follow Up Adherence, Assessed through Electronic Record Review

The number of scheduled follow-up appointments versus the number of attended follow-up appointments will be compared for each patient through electronic record review.

Time frame
12 months
2

Diabetic Retinopathy Progression, Assessed through Electronic Health Record Review

Electronic health records and ocular imaging will be reviewed to determine whether patients' diabetic retinopathy has progressed or improved. The numbers of patients with mild, moderate, severe, and proliferative diabetic retinopathy will be compared between groups at the end of the study period.

Time frame
12 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: